SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 78285.07
521.16 (0.67%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Rainbow Childrens Medicare Ltd.	Q V PT	14,620 Small Cap	1,441.40 (0.14%)	58.56	8.67	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Senores Pharmaceuticals Ltd.	Q V+ PT	6,356 Small Cap	1,363.40 (-1.22%)	310.07	8.37	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,777 Small Cap	2,653.20 (-0.85%)	40.88	8.28	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Fortis Healthcare Ltd.	Q V+ PT	73,586 Mid Cap	979.50 (0.49%)	321.04	8.01	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Fischer Medical Ventures Ltd.	Q V PT	2,573 Small Cap	37.87 (-3.66%)	N/A	7.94	96.10	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Metropolis Healthcare Ltd.	Q V PT	11,521 Small Cap	573.15 (3.14%)	62.54	7.85	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Dr. Agarwals Health Care Ltd.	Q V PT	15,204 Small Cap	481.15 (0.31%)	114.51	7.53	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Blue Jet Healthcare Ltd.	Q V PT	9,618 Small Cap	563.50 (1.63%)	39.44	7.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Marksans Pharma Ltd.	Q V+ PT	11,964 Small Cap	259.40 (-1.74%)	39.09	7.11	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,432 Small Cap	5,004.95 (-0.56%)	34.51	6.98	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Nephrocare Health Services Ltd.	Q V+ PT	6,745 Small Cap	675.80 (0.54%)	N/A	6.98	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Wanbury Ltd.	Q V+ PT	1,003 Small Cap	284.20 (-1.04%)	15.01	6.87	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Jubilant Pharmova Ltd.	Q V+ PT	15,430 Small Cap	985.85 (1.77%)	789.08	6.79	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Concord Biotech Ltd.	Q V PT	13,391 Small Cap	1,284 (0.31%)	51.48	6.66	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	RPG Life Sciences Ltd.	Q V+ PT	3,997 Small Cap	2,419.65 (0.12%)	34.75	6.61	12.70	21.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,554 Small Cap	236.90 (0.36%)	36.2	6.57	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Mankind Pharma Ltd.	Q V PT	1,04,535 Mid Cap	2,540.25 (0.36%)	51.49	6.4	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	7,761 Small Cap	261.65 (9.41%)	5.47	6.37	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Wockhardt Ltd.	Q V+ PT	31,497 Small Cap	1,915.70 (-1.17%)	146.14	6.3	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Innova Captab Ltd.	Q V PT	5,474 Small Cap	955.10 (-0.15%)	65.31	6.16	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Glenmark Pharmaceuticals Ltd.	Q V+ PT	62,362 Mid Cap	2,270.45 (2.74%)	47.05	6.1	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Healthcare Global Enterprises Ltd.	Q V+ PT	9,828 Small Cap	651.25 (-1.06%)	666.89	6.06	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Jupiter Life Line Hospitals Ltd.	Q V PT	9,539 Small Cap	1,459.65 (0.33%)	50.01	5.95	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Supriya Lifescience Ltd.	Q V+ PT	7,884 Small Cap	865.75 (-11.62%)	33.32	5.82	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Suraksha Diagnostic Ltd.	Q V PT	1,425 Small Cap	270.85 (-1.01%)	43.83	5.76	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Ipca Laboratories Ltd.	Q V+ PT	45,182 Mid Cap	1,780.35 (-0.03%)	39.88	5.66	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Gufic Biosciences Ltd.	Q V PT	3,921 Small Cap	375.05 (-4.08%)	59.56	5.66	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Vimta Labs Ltd.	Q V+ PT	2,616 Small Cap	565.15 (-3.45%)	32.58	5.62	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Poly Medicure Ltd.	Q V PT	17,029 Small Cap	1,686.45 (0.38%)	50.88	5.6	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Caplin Point Laboratories Ltd.	Q V PT	19,272 Small Cap	2,625.15 (3.54%)	31.12	5.56	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Fermenta Biotech	395	14.21%
Tarsons Products	293.10	10.42%
Sun Pharma Adv. Res	261.65	9.41%
Artemis MedicareServ	276.30	6.11%
Rubicon Research	1,362.85	4.61%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Supriya Lifescience	865.75	-11.62%
Acutaas Chemicals	3,514.30	-4.78%
Gufic Biosciences	375.05	-4.08%
Suven Life Sciences	314.90	-3.86%
Fischer Medical	37.87	-3.66%

News about Top Pharma Companies in India

Jul, 2026

Blue Jet Healthcare informs about resignation of statutory auditors

Blue Jet Healthcare has informed that the Board of Directors of Blue Jet Healthcare at its meeting held on May 25, 2026, has approved the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, including the comparative figures for the financial year ended March 31, 2025, prepared in accordance with the applicable provisions of the Companies Act, 2013 and the applicable accounting standards. A copy of the audited standalone financial statements together with the notes and schedules thereto along with the audit report thereon is enclosed. The audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, are subject to adoption by the shareholders of the Company at the ensuing Annual General Meeting. The above intimation will also be available on the website of the Company, www.bluejethealthcare.com.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Concord Biotech informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has enclosed copies of the newspaper advertisements published for the information of the shareholders, in compliance with the applicable provisions of the SEBI Listing Regulations and the Companies Act, 2013, read with the rules made thereunder. The advertisements contain information regarding the Company's 41st Annual General Meeting, notice of candidature for the office of Director, the record date, and the availability of the e-voting facility. Financial Express (English, All Editions); and Financial Express (Gujarati, Ahmedabad Editions).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Sun Pharma Advanced Research Company informs about confirmation certificate

Sun Pharma Advanced Research Company has informed that it enclosed the Confirmation Certificate dated July 01, 2026, received from the Company’s Registrar and Share Transfer Agent, MUFG Intime (India) for the quarter ended June 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals informs about press release

Glenmark Pharmaceuticals has informed about the launch of Olanzapine for Injection, 10 mg/vial, Single?Dose Vial. Glenmark’s Olanzapine for Injection is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa® IntraMuscular Injection 10 mg/vial, of Cheplapharm Registration GmbH [NDA 021253]. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Fortis Healthcare gains on signing O&M agreement with Dion Group

The O&M agreement is for a 300-bed greenfield multi-specialty hospital to be developed at Dion Riverside Township, Trishulia in Cuttack, Odisha

Jul, 2026

Glenmark Pharmaceuticals’ arm launches Olanzapine for Injection

The launch of Olanzapine for Injection underscores its strategic focus on growing a robust injectables portfolio and strengthening its presence within the institutional channel

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Astrazeneca Pharma India Ltd.	20,745 Crore
2	Sanofi Consumer Healthcare India Ltd.	10,662 Crore
3	Procter & Gamble Health Ltd.	10,560 Crore
4	Torrent Pharmaceuticals Ltd.	1,61,290 Crore
5	Glaxosmithkline Pharmaceuticals Ltd.	40,535 Crore
6	Acutaas Chemicals Ltd.	30,215 Crore
7	Rubicon Research Ltd.	21,545 Crore
8	CORONA Remedies Ltd.	12,453 Crore
9	Laurus Labs Ltd.	83,293 Crore
10	Thyrocare Technologies Ltd.	8,832 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,852	54,930	35.39	11.51	24.16	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,61,290	74.55	19.23	39.18	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,371	41,550	39.35	9.18	26.59	25.35
Lupin Ltd. (M)	Somewhat Good	2,492	1,13,215	21.23	5.04	12.28	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,148	1,13,815	22.58	4.38	13.82	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,529	83,293	97.06
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,391	37,944	46.04
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,61,290	43.21
Aurobindo Pharma Ltd. (M)	Very Good	1,594	93,217	33.87
Gland Pharma Ltd. (S)	Very Good	2,462	40,588	31.41
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,391	37,944	56.29	9.40	34.09	15.51
Mankind Pharma Ltd. (M)	Very Good	2,540	1,04,535	51.30	6.38	32.20	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,371	41,550	39.35	9.18	26.59	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,14,730	27.34	3.04	15.25	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,61,290	74.55	19.23	39.18	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,148	1,13,815	22.58	4.38	13.82	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,913	4,56,989	39.81	5.47	22.81	23.50
Abbott India Ltd. (M)	Very Good	26,852	54,930	35.39	11.51	24.16	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,14,730	27.34	3.04	15.25	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,270	62,362	45.79	5.93	12.16	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Blue Jet Healthcare informs about resignation of statutory auditors

Concord Biotech informs about newspaper publication

Sun Pharma Advanced Research Company informs about confirmation certificate

Glenmark Pharmaceuticals informs about press release

Fortis Healthcare gains on signing O&M agreement with Dion Group

Glenmark Pharmaceuticals’ arm launches Olanzapine for Injection

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.